Drug Standards
- (2)
- (4)
- (1)
- (3)
- (3)
- (665)
- (3)
- (27)
- (1)
- (6)
- (27)
- (61)
- (24)
- (1)
- (2)
- (35)
- (367)
- (45)
- (1)
- (2)
- (1)
- (5)
- (5)
- (4)
- (2)
- (7)
- (1)
- (5)
- (4)
- (3)
- (3)
- (1)
- (3)
- (2)
- (2)
- (1)
- (2)
- (3)
- (4)
- (2)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (5)
- (1)
- (2)
- (4)
- (1)
- (1)
- (3)
- (5)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (3)
- (1)
- (1)
- (3)
- (4)
- (2)
- (2)
- (1)
- (4)
- (4)
- (5)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (4)
- (3)
- (1)
- (4)
- (1)
- (2)
- (1)
- (5)
- (2)
- (2)
- (1)
- (5)
- (7)
- (3)
- (1)
- (1)
- (1)
- (4)
- (1)
- (3)
- (1)
- (4)
- (1)
- (8)
- (2)
- (1)
- (5)
- (13)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (4)
- (1)
- (5)
- (1)
- (1)
- (2)
- (1)
- (6)
- (2)
- (1)
- (2)
- (2)
- (1)
- (3)
- (1)
- (2)
- (2)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1)
- (2)
- (4)
- (3)
- (1)
- (1)
- (5)
- (3)
- (2)
- (5)
- (1)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (4)
- (4)
- (1)
- (2)
- (2)
- (1)
- (2)
- (4)
- (5)
- (2)
- (1)
- (3)
- (2)
- (2)
- (11)
- (1)
- (2)
- (2)
- (2)
- (5)
- (5)
- (4)
- (2)
- (4)
- (2)
- (1)
- (2)
- (5)
- (2)
- (2)
- (1)
- (2)
- (3)
- (2)
- (2)
- (5)
- (3)
- (2)
- (2)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (2)
- (3)
- (2)
- (2)
- (3)
- (2)
- (1)
- (1)
- (5)
- (1)
- (2)
- (5)
- (5)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (7)
- (2)
- (2)
- (1)
- (3)
- (1)
- (3)
- (2)
- (5)
- (2)
- (2)
- (2)
- (2)
- (5)
- (2)
- (1)
- (6)
- (3)
- (2)
- (1)
- (5)
- (5)
- (2)
- (2)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (5)
- (1)
- (2)
- (4)
- (1)
- (3)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (5)
- (2)
- (2)
- (1)
- (1)
- (2)
- (8)
- (4)
- (14)
- (7)
- (8)
- (1)
- (3)
- (1)
- (6)
- (1)
- (1)
- (5)
- (2)
- (1)
- (1)
- (2)
- (20)
- (4)
- (5)
- (1)
- (3)
- (2)
- (1)
- (7)
- (8)
- (7)
- (2)
- (1)
- (2)
- (1)
- (3)
- (5)
- (5)
- (1)
- (3)
- (1)
- (3)
- (6)
- (3)
- (3)
- (1)
- (2)
- (26)
- (54)
- (5)
- (11)
- (4)
- (6)
- (6)
- (16)
- (1)
- (129)
- (3)
- (1)
- (2)
- (5)
- (4)
- (14)
- (38)
- (3)
- (13)
- (12)
- (7)
- (1)
- (6)
- (6)
- (6)
- (1)
- (1)
- (1)
- (1)
- (1)
- (12)
- (38)
- (5)
- (1)
- (2)
- (1)
- (1)
- (12)
- (2)
- (15)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (6)
- (15)
- (2)
- (1)
- (19)
- (3)
- (18)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (29)
- (3)
- (2)
- (1)
- (2)
- (1)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (44)
- (2)
- (27)
- (1)
- (73)
- (6)
- (73)
Filtered Search Results
Zanamivir Hydrate 98.0+%, TCI America™
CAS: 551942-41-7 Molecular Formula: C12H22N4O8 Molecular Weight (g/mol): 350.33 MDL Number: MFCD00866966 InChI Key: OELRRAURPSTFEX-UHFFFAOYNA-N PubChem CID: 636424 IUPAC Name: 4-[(diaminomethylidene)amino]-3-acetamido-2-(1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid hydrate SMILES: O.CC(=O)NC1C(C=C(OC1C(O)C(O)CO)C(O)=O)N=C(N)N
| PubChem CID | 636424 |
|---|---|
| CAS | 551942-41-7 |
| Molecular Weight (g/mol) | 350.33 |
| MDL Number | MFCD00866966 |
| SMILES | O.CC(=O)NC1C(C=C(OC1C(O)C(O)CO)C(O)=O)N=C(N)N |
| IUPAC Name | 4-[(diaminomethylidene)amino]-3-acetamido-2-(1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid hydrate |
| InChI Key | OELRRAURPSTFEX-UHFFFAOYNA-N |
| Molecular Formula | C12H22N4O8 |
Lisinopril Dihydrate 98.0+%, TCI America™
Molecular Formula: C21H33N3O6 Molecular Weight (g/mol): 423.51 MDL Number: MFCD01698825 InChI Key: BAVDEDVBIHTHJQ-UVJOBNTFSA-N Synonym: 1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline PubChem CID: 22887897 IUPAC Name: (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid;hydrate SMILES: C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O.O
| PubChem CID | 22887897 |
|---|---|
| Molecular Weight (g/mol) | 423.51 |
| MDL Number | MFCD01698825 |
| SMILES | C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O.O |
| Synonym | 1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline |
| IUPAC Name | (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid;hydrate |
| InChI Key | BAVDEDVBIHTHJQ-UVJOBNTFSA-N |
| Molecular Formula | C21H33N3O6 |
Apomorphine Hydrochloride, Hemihydrate, USP, 98.5-101.5%, Spectrum™ Chemical
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
CAS: 41372-20-7 Molecular Weight (g/mol): 312.8 g/mol
| CAS | 41372-20-7 |
|---|---|
| Molecular Weight (g/mol) | 312.8 g/mol |
Bimatoprost, Thermo Scientific™
CAS: 155206-00-1 Molecular Formula: C25H37NO4 Molecular Weight (g/mol): 415.57 MDL Number: MFCD03411999 InChI Key: AQOKCDNYWBIDND-FTOWTWDKSA-N IUPAC Name: (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl]-N-ethylhept-5-enamide SMILES: CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1
| CAS | 155206-00-1 |
|---|---|
| Molecular Weight (g/mol) | 415.57 |
| MDL Number | MFCD03411999 |
| SMILES | CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1 |
| IUPAC Name | (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl]-N-ethylhept-5-enamide |
| InChI Key | AQOKCDNYWBIDND-FTOWTWDKSA-N |
| Molecular Formula | C25H37NO4 |
Ribavirin Impurity Standard, MilliporeSigma™ Supelco™
Analog of the imidazole nucleotide intermediates in purine nucleotide biosynthesis.
Abacavir Impurity Standard, British Pharmacopoeia (BP) Reference Standard, MilliporeSigma™ Supelco™
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, has been developed and issued under the Authority of the issuing Pharmacopoeia.
Etravirine, Thermo Scientific™
CAS: 269055-15-4 Molecular Formula: C20H15BrN6O Molecular Weight (g/mol): 435.29 MDL Number: MFCD09837879 InChI Key: PYGWGZALEOIKDF-UHFFFAOYSA-N Synonym: 4-((6-Amino-5-bromo-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile IUPAC Name: 4-({6-amino-5-bromo-2-[(4-cyanophenyl)amino]pyrimidin-4-yl}oxy)-3,5-dimethylbenzonitrile SMILES: CC1=CC(=CC(C)=C1OC1=NC(NC2=CC=C(C=C2)C#N)=NC(N)=C1Br)C#N
| CAS | 269055-15-4 |
|---|---|
| Molecular Weight (g/mol) | 435.29 |
| MDL Number | MFCD09837879 |
| SMILES | CC1=CC(=CC(C)=C1OC1=NC(NC2=CC=C(C=C2)C#N)=NC(N)=C1Br)C#N |
| Synonym | 4-((6-Amino-5-bromo-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile |
| IUPAC Name | 4-({6-amino-5-bromo-2-[(4-cyanophenyl)amino]pyrimidin-4-yl}oxy)-3,5-dimethylbenzonitrile |
| InChI Key | PYGWGZALEOIKDF-UHFFFAOYSA-N |
| Molecular Formula | C20H15BrN6O |
Butoconazole nitrate, Thermo Scientific™
CAS: 64872-77-1 Molecular Formula: C19H18Cl3N3O3S Molecular Weight (g/mol): 474.78 MDL Number: 00058159 InChI Key: ZHPWRQIPPNZNML-UHFFFAOYNA-N IUPAC Name: 1-[4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)sulfanyl]butyl]-1H-imidazole; nitric acid SMILES: O[N+]([O-])=O.ClC1=CC=C(CCC(CN2C=CN=C2)SC2=C(Cl)C=CC=C2Cl)C=C1
| CAS | 64872-77-1 |
|---|---|
| Molecular Weight (g/mol) | 474.78 |
| MDL Number | 00058159 |
| SMILES | O[N+]([O-])=O.ClC1=CC=C(CCC(CN2C=CN=C2)SC2=C(Cl)C=CC=C2Cl)C=C1 |
| IUPAC Name | 1-[4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)sulfanyl]butyl]-1H-imidazole; nitric acid |
| InChI Key | ZHPWRQIPPNZNML-UHFFFAOYNA-N |
| Molecular Formula | C19H18Cl3N3O3S |